[1]
Sobańska, N., Teichman, R., Banasiak, A.P., Kasprowicz, J., Pierzchała, J.R., Hyjek, M., Abram, K., Banaś, P., Bednarz, K. and Adamus, J. 2023. Gliflozins and their beneficial hypoglycaemic effect profile and prevention of cardiovascular complications in patients treated for type II diabetes mellitus. Quality in Sport. 9, 2 (Feb. 2023), 11–17. DOI:https://doi.org/10.12775/QS.2023.09.02.001.